Spelling suggestions: "subject:"inflammatory reaction"" "subject:"nflammatory reaction""
1 |
Ostéolyse péri-prothétique associée aux particules d'usure de polyéthylène : rôle de l'inflammation et des macrophages / Polyethylene particules _ induced periprosthetic osteolysis : the inflammation and macrophages perspectiveGibon, Emmanuel 27 June 2017 (has links)
Devant le succès maintenant bien démontré des prothèses totales de hanche, les chirurgiens sont amenés à proposer ce traitement chez des patients dont l’espérance de vie ne cesse d’augmenter. Parallèlement, une population plus jeune et active a aussi recours à ce traitement permettant de reprendre rapidement ses activités professionnelles et de loisirs. Des progrès exceptionnels ont été réalisés par les bio-ingénieurs en collaboration avec les chirurgiens dans la production industrielle d’implants en polyéthylène désormais très performants avec des taux d’usure très faibles. Néanmoins, bien que très diminuée, cette usure aboutit à la production de particules micrométriques libérées autour de la prothèse. Ces particules d’usure interagissent avec les tissus environnants et notamment les macrophages circulants, conduisant à une réaction inflammatoire. Les macrophages, cellules clés de cette cascade inflammatoire, subissent une activation par phagocytose ou par contact membranaire avec les particules puis une polarisation engendrant la libération de molécules à fort pouvoir inflammatoire : cytokines, chemokines, dérivés oxygénés, TNF-α et autres conduisant au maintien d’un niveau inflammatoire élevé autour de la prothèse. A long terme, le risque est l’évolution vers l’ostéolyse péri-prothétique et le descellement aseptique dont le seul traitement est la reprise chirurgicale, intervention difficile chez des patients qui ont vieilli. La compréhension des mécanismes biologiques de cette réaction inflammatoire permet le développement de stratégies modulant ou inversant cette inflammation afin d’augmenter la longévité des prothèses totales de hanche. / Total hip replacements are now very succesful and surgeons perform this procedure in patients with an increasing longevity. Young and active patients are also candidates for this surgery allowing them to quickly resume their professional and recreational activities. Exceptional advances have been made by bio-engineers and surgeons in the production of highly efficient polyethylene implants which have very low wear rates. Nevertheless, wear remains and wear particles are still released around the implant. These particles react with the surrounding tissues especially macrophages, leading to an inflammatory reaction. Macrophages are then activated and subsequently polarize releasing inflammatory factors such as cytokines, chemokines, oxide species and TNF-?. This could lead peri-prosthetic osteolysis and aseptic loosening requiring revision surgery, a difficult procedure. Understanding the biological mecanisms of this inflammatory reaction may help creating strategies to mitigate or reverse this inflammation with the goal to increase the longevity of these implants.
|
2 |
Modulation expérimentale des populations cellulaires endogènes améliorant la régénération du système nerveux central après lésion médullaire.Bouhy, Delphine 19 October 2007 (has links)
Macrophages (monocytes/microglia) could play a critical role in central nervous system repair. We have previously found a synchronism between the regression of spontaneous axonal regeneration and the deactivation of macrophages 34 wk after a compression-injury of rat spinal cord. To explore whether reactivation of endogenous macrophages might be beneficial for spinal cord repair, we have studied the effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in the same paraplegia model and in cell cultures. There is significant, though transient, improvement of locomotor recovery after a single delayed intraperitoneal injection of 2g GM-CSF. This improvement is associated with an increased expression of 5HT at the level of the CPG (T13-L2). At longer survival delays, axonal regeneration is significantly enhanced in GM-CSF-treated rats. We then studied the effects of GM-CSF on brain-derived neurotrophic factor (BDNF)secretion by macrophages/microglia, inflammatory reaction and phagocytosis by macrophages/microglia. In vivo, at short post-treatment delays, we found that GM-CSF increases significantly the expression of Cr3 and BDNF by macrophages at the lesion site. In vitro, BV2 microglial cells expressed higher levels of BDNF in the presence of GM-CSF and neurons cocultured with microglial cells activated by GM-CSF generated more neurites, an effect blocked by a BDNF antibody. In vivo, we showed that GM-CSF treatment (either immediate or delayed) does not increase IL-6 expression by macrophages/microglia or astrocytes. We showed that a delayed GM-CSF treatment down regulates IL-1 expression by astrocytes. In vivo, we showed that a delayed GM-CSF treatment can decrease MAG expression at the lesion site.
These experiments suggest that GM-CSF could be an interesting treatment option for spinal cord injury and that its beneficial effects might be mediated by BDNF.
|
3 |
Identification des mécanismes cellulaires et moléculaires à l'origine de la perte précoce des îlots pancréatiques au cours de la transplantation / Identification of cellular and molecular mechanisms responsible for early loss of islets during transplantationVivot, Kevin 28 September 2012 (has links)
De l’isolement des îlots pancréatiques à leur implantation, l’inflammation est omniprésente au cours de la transplantation d’îlots pancréatiques. Le maintien d’une inflammation contrôlée est essentiel pour préserver la survie et la fonctionnalité du greffon à court et long terme. L’objectif de ce travail de thèse est d’identifier précisément les mécanismes inflammatoires à l’origine de la perte précoce des îlots et de déterminer des cibles thérapeutiques pour limiter ces réactions inflammatoires.Nous avons ainsi démontré que les conditions de culture induisent des réactions à l’origine du développement d’un phénotype pro-inflammatoire et pro-oxydant propre à l’îlot. Cette induction se caractérise par une élévation de la sécrétion de cytokines, de chimiokines pro-inflammatoires, une activation des voies de l’inflammation Toll-like récepteurs (TLRs)-dépendantes et une génération d’espèces réactives de l’oxygène (ROS). Toutefois, ce processus peut être prévenu par l’activation de l’Hème oxygénase-1 (HO-1), une enzyme anti-oxydante et anti-inflammatoire.Par l’étude des réactions inflammatoires sur un modèle animal de transplantation mimant les conditions de transplantation humaine, nous avons démontré qu’un changement des médiateurs plasmatiques de l’inflammation et du protéome hépatique s’opère 12 heures après transplantation. De plus, ces résultats sont associés à une infiltration des îlots par les cellules immunitaires qui s’organise 12 heures après transplantation. Nous avons également établi le rôle anti-inflammatoire de la rapamycine (une drogue immunomodulatrice) sur les îlots et les macrophages in vitro. Nous avons ainsi démontré que l’usage de la rapamycine avec la mise en place d’un pré-traitement des îlots et du receveur avant la greffe serait envisageable. Ces travaux ont permis de caractériser les mécanismes inflammatoires mis en oeuvre immédiatement avant et après transplantation. Ainsi, ces données offrent de nouvelles pistes thérapeutiques susceptibles de prévenir et/ou limiter l’inflammation au cours de la transplantation d’îlots pancréatiques. / From isolation of pancreatic islets to their implantation, the inflammation is ubiquitous in the pancreatic islet transplantation. Maintaining a controlled inflammation is essential to preserve the survival of the graft and the functionality in the short and long term. The objective of this work is to identify precisely the inflammatory mechanisms behind the early loss of islets and identify therapeutic targets to reduce these inflammatory reactions. We have demonstrated that culture conditions induce reactions causing the development of a specific proinflammatory and pro-oxydant phenotype islet. This induction is characterized by an increase in the secretion of cytokines, chemokines pro-inflammatory activation pathways of inflammation Toll-like receptors (TLRs) -dependent and generation of reactive oxygen species (ROS). However, this process can be prevented by the activation of Heme oxygenase-1 (HO-1), an antioxidant and anti-inflammatory enzyme.By studying the inflammatory responses in an animal model of transplantation mimicking the conditions of human transplantation, we demonstrated that a change of plasma mediators of inflammation and liver proteome occurs 12 hours after transplantation. Furthermore, these results are associated with infiltration of the islets by immune cells which organizes 12 hours after transplantation. We also determined the anti-inflammatory role of rapamycin (an immunomodulatory drug) on the islets and macrophages in vitro. We have thus demonstrated that the use of rapamycin with the establishment of a pre-treatment of islets and recipient before transplantation could be considered. These studies have characterized the inflammatory mechanisms implemented immediately before and after transplantation. Thus, these data provide new therapeutic approaches that can prevent and / or reduce inflammation during pancreatic islet transplantation
|
4 |
Estudo histológico da ação do corticosteróide injetável no processo agudo de cicatrização das pregas vocais de coelhos / Histologic study of corticosteroid injection in the acute vocal fold wound healing in a rabbit modelCampagnolo, Andréa Maria 29 October 2009 (has links)
Corticosteróides injetáveis têm sido usados em fonocirurgia com o intuito de se prevenir fibrose da prega vocal pelos seus efeitos na cicatrização e assegurar uma melhor qualidade vocal. O objetivo deste estudo é avaliar histologicamente os efeitos da infiltração de dexametasona no processo agudo de cicatrização, 3 e 7 dias após uma lesão induzida cirurgicamente na prega vocal de coelhos, através da análise quantitativa da reação inflamatória e da deposição de colágeno. Uma incisão cirúrgica foi realizada nas pregas vocais de 12 coelhos, seguido da injeção de 0,1ml de dexametasona na prega vocal esquerda. A prega vocal direita não recebeu nenhuma injeção e serviu como grupo controle. As laringes foram coletadas 3 e 7 dias após a cirurgia. As pregas vocais foram histologicamente analisadas com hematoxilina-eosina para quantificar a resposta inflamatória e picrossírius-red para quantificar a deposição de colágeno. Quantitativamente, não houve diferença significativa na resposta inflamatória das pregas vocais com corticosteróide em relação ao controle. A deposição de colágeno no grupo com corticóide foi estatisticamente menor em 3 dias e permaneceu menor em 7 dias após a lesão cirúrgica (p=0,002). Esses resultados sugerem que os corticosteróides diminuem a deposição do colágeno no processo agudo da cicatrização / Injectable corticosteroids have been used in phonosurgery to prevent scarring of the vocal fold due to their effects on wound healing, and to assure better voice quality. The aim of this study is to evaluate histologically the effects of dexamethasone infiltration on acute vocal fold wound healing in rabbits 3 and 7 days after surgically-induced injury, by quantification of the inflammatory reaction and collagen deposition. A standardized surgical incision was made in the vocal folds of 12 rabbits, and 0.1 ml dexamethasone (4 mg/ml) was injected into the left vocal fold. The right vocal fold was not injected and served as the control. The larynges were collected 3 and 7 days after surgery. For histological analysis, the vocal folds were stained with hematoxylin-eosin for quantification of the inflammatory response and with picrosirius red for quantification of collagen deposition. There was no quantitative difference in the inflammatory response between vocal folds injected with the corticosteroid and the control folds. However, collagen deposition was significantly lower in the corticosteroid-treated group at 3 and 7 days after the injury (p = 0.002). The present results suggest that dexamethasone reduces collagen deposition during acute vocal fold wound healing
|
5 |
Anatomopatologia de implantes de peric?rdio bovino conservados em diferentes concentra??es de glutaralde?do em parede abdominal de camundongos / Anatomopathology of bovine pericardium implants preserved in differents concentrations of glutaraldehyde in mice abdominal wall.Costa, Cl?udia Borges da 26 June 2009 (has links)
Made available in DSpace on 2016-04-28T20:18:33Z (GMT). No. of bitstreams: 1
2009 - Claudia Borges da Costa.pdf: 2611847 bytes, checksum: bac6f485f20793fe627e66f8a53c973e (MD5)
Previous issue date: 2009-06-26 / This experiment aimed at recognizing and quantifying the possible macro and microscopic
tissue alterations that may occur with the application of bovine pericardium preserved in
different concentrations of glutaraldehyde on the abdominal wall. Besides, it also intended to
identify the possible interferences in the implant incorporation, according to the variation in
the concentration of each solution. Fresh bovine pericardium, after cleaning and the removal
of fat, were fractioned and treated with 98% glycerin solution for 30 days (control groups) or
with 0.625%, 1% and 1.5% glutaraldehyde solution for 18 days (experimental groups). The
fragments were implanted on the abdominal wall of 60 mice (n=15 per treatment) for 7, 14
and 30 days. After each of these periods, five animals of each group were sacrificed for
collection, and macro and microscopic analysis of tissue samples. It was observed that the
inflammatory reaction in the groups treated with glycerin and 0.625% glutaraldehyde was
similar in terms of inflammatory cells infiltration and the repairing process. The groups whose
implants were treated with 1% glutaraldehyde chronically presented (30 days) not only more
intense fibrosis and necrosis, when compared to other glutaraldehyde groups, but also tissue
destruction. These were also observed in the animals that received the pericardium treated
with 1.5% glutaraldehyde, analyzed after 14 and 30 days, what leads to the conclusion that
this concentration is unviable for the treatment of biological membranes. / Este experimento teve como objetivo reconhecer e quantificar as poss?veis altera??es
teciduais macro e microsc?picas que podem ocorrer ap?s a aplica??o de peric?rdio bovino
conservado em diferentes concentra??es de glutaralde?do em parede abdominal. Tamb?m
foram identificadas poss?veis interfer?ncias na incorpora??o do enxerto de acordo com a
varia??o da concentra??o da solu??o de tratamento. Peric?rdios bovinos frescos, ap?s limpeza
e retirada de gordura, foram fracionados em fragmentos de 1cm2 e tratados com solu??o de
glicerina 98% por 30 dias (grupos controle) ou com solu??o de gutaralde?do 0,625%, 1% e
1,5% por 18 dias (grupos experimentais). Os fragmentos foram implantados na parede
abdominal de 60 camundongos (n=15 por tratamento) por 7, 14 e 30 dias e ap?s estes
per?odos, cinco animais de cada grupo foram sacrificados para coleta e an?lise macro e
microsc?pica das amostras teciduais. Observou-se que a resposta inflamat?ria dos grupos com
tratamento com glicerina e com glutaralde?do 0,625% foi semelhante tanto na infiltra??o das
c?lulas inflamat?rias quanto no processo de repara??o. Os grupos com implantes tratados com
glutaralde?do 1% apresentaram cronicamente (30 dias) a presen?a de fibrose e necrose mais
intensa na musculatura da parede abdominal, quando comparado com os outros grupos de
glutaralde?do, al?m de destrui??o tecidual. Esta tamb?m foi observada nos animais que
receberam peric?rdio tratado com glutaralde?do 1,5% e foram analisados com 14 e 30 dias, o
que permitiu a conclus?o de que esta concentra??o ? invi?vel para o tratamento de membranas
biol?gicas.
|
6 |
Efeito de dois diluidores comerciais na qualidade do sêmen, fertilidade e reação uterina pós-inseminação em ovelhasFischer Neto, Arthur January 2009 (has links)
Este estudo teve por objetivo avaliar os efeitos de dois diluentes comerciais, Dilutris® (SEMENCON – Produtos Agropecuários Ltda., Porto Alegre, RS, Brasil) e TQC Holding Plus® (Nutricell – Nutrientes Celulares Ltda., Campinas, SP, Brasil), na qualidade do sêmen, nas taxas de concepção utilizando inseminação artificial cervical (IAC) e por laparoscopia (IAL) e na reação inflamatória uterina após a inseminação laparoscópica. Para os testes in vitro do sêmen foram coletados seis ejaculados de dois carneiros. Cada ejaculado foi dividido em cinco frações de 0,20 mL, e acrescentado a cada fração o volume de diluidor equivalente a concentração da dose inseminante: para IAC (100x106 espermatozóides) e para IAL (40x106 espermatozóides), formando quatro tratamentos T1, T2, T3 e T4, respectivamente: Dilutris®/cervical; Dilutris®/laparoscopia; Holding®/cervical; Holding®/laparoscopia. Foram avaliadas a motilidade/ vigor, testes de termo-resistência e hiposmótico de cada fração. A motilidade e o vigor não diferiram entre os tratamentos e foram semelhantes aos verificados no sêmen fresco. No teste hiposmótico, os valores verificados no T4 e T1 foram semelhantes e não diferiram dos observados no sêmen fresco. Os valores observados nos tratamentos T2 e T3 não diferiram entre si, mas foram significativamente inferiores (P<0,05) aos verificados no T4. Os resultados do teste de TTR verificados em todos os tratamentos utilizados, foram superiores ao valor mínimo de 30% preconizado pelo CBRA. O T1 apresentou valor significativamente inferior (P<0,05) ao dos demais tratamentos. Para a inseminação artificial, 208 fêmeas tiveram o estro sincronizado com esponjas vaginais contendo 60 mg de MAP por 13 dias e aplicação de 400 UI de eCG no momento da retirada. Foram inseminadas pela via cervical (IAC) ou por laparoscopia (IAL), 54 horas e 60 horas, respectivamente, após a retirada do dispositivo intra-vaginal, com sêmen diluído com Dilutris®, Holding® ou solução fisiológica (Grupo controle). Independentemente do diluente utilizado, os índices obtidos na IAL foram superiores (P<0,05) aos obtidos pela IAC. Na IAC a taxa de gestação obtida no grupo inseminado com o diluente TQC Holding Plus® (45,6%), foi semelhante à verificada no grupo controle (48,9%). Já no grupo que foi inseminado com Dilutris®, a taxa de gestação (29%) foi inferior à obtida no grupo controle (P<0,05). Com relação aos aspectos histológicos, verificou-se um infiltrado inflamatório de neutrófilos de grau discreto a acentuado nos úteros inseminados por laparoscopia com Dilutris®, de ausente a moderado nos úteros inseminados com TQC Holding Plus®, e no grupo controle não houve presença de infiltrado inflamatório de neutrófilos. Podese concluir que na avaliação in vitro, o meio de manutenção de embriões TQC Holding Plus® não causou efeitos negativos na qualidade do sêmen, enquanto que o meio diluidor Dilutris® foi menos efetivo na manutenção da qualidade do sêmen. O local de deposição do sêmen teve influência significativa no índice de fertilidade (P<0,05). Por laparoscopia as taxas de gestação foram semelhantes independentemente do diluidor utilizado. Um maior número de avaliações uterinas são necessárias para um melhor conhecimento da reação inflamatória intra-uterina em ovinos inseminados por laparoscopia. / This study aims to assess the effects of two commercial diluents, Dilutris® (SEMENCON – Produtos Agropecuários Ltda., Porto Alegre, RS, Brazil) and TQC Holding Plus® (Nutricell – Nutrientes Celulares Ltda., Campinas, SP, Brazil), on semen quality, conception rates using Cervical Artificial Insemination (CAI) and Laparoscopic Artificial Insemination (LAI), and uterine inflammatory reactions after the laparoscopic insemination. For the in vitro tests with the semen, six ejaculates of two rams were collected. Each ejaculate was divided into five fractions of 0.20 mL, and we added to each fraction the volume of extender equivalent to the concentration of the inseminant dose: for CAI (100x106 spermatozoa) and for LAI (40x106 spermatozoa), forming four treatments T1, T2, T3, and T4, respectively: Dilutris®/cervical; Dilutris®/laparoscopy; Holding®/cervical; Holding®/laparoscopy. The motility/vigor, thermo-resistance and hypoosmotic tests of each fraction was evaluated. The motility and vigor were not different between the treatments and were similar to those verified in fresh semen. In the hypoosmotic test, the values verified in T4 and T1 were similar and were not different from those observed in fresh semen. The values observed in T2 and T3 treatments have not differed between them, but were significantly lower (P<0.05) to those verified in T4. Results of the TTR test verified in all used treatments were superior to the minimum value of 30% preconized by CBRA. T1 presented a significantly lower value (P<0.05) compared to the other treatments. For artificial insemination, 208 female had their estrus synchronized with vaginal sponges containing 60 mg of MAP for 13 days and the application of 400 UI of eCG at the moment of removal. They were inseminated by cervical via (CAI) or by laparoscopy (LAI), 54 and 60 hours, respectively, after the removal of the intravaginal device, with semen diluted with Dilutris®, Holding® or physiological solution (control group). Independently of the extender used, the obtained rates in the LAI were superior (P<0.05) to those obtained with the CAI. In CAI the pregnancy rate obtained in the inseminated group with the TQC Holding Plus® diluent (45.6%) was similar to the one verified in the control group (48.9%). In the group inseminated with Dilutris®, the pregnancy rate (29%) was inferior to the obtained in the control group (P<0.05). Related to the histological aspects, we verified a discreet to accentuated degree of neutrophils inflammatory infiltrate in the uterus inseminated by laparoscopy with Dilutris®, from absent to moderate in uterus inseminated with TQC Holding Plus®, and in the control group there was not inflammatory infiltrate of neutrophils. We can conclude that in the in vitro evaluation, the embryos maintenance means TQC Holding Plus® has not caused negative effects in the quality of the semen, while the Dilutris® extender was less effective to maintain the quality of the semen. The semen deposition site has a significant impact in the fertility rate (P<0.05). By laparoscopy the pregnancy rates were similar independently of the extender used. A larger number of uterine analyses are required for a better knowledge of the intrauterine inflammatory reaction in sheep inseminated by laparoscopy.
|
7 |
Efeito de dois diluidores comerciais na qualidade do sêmen, fertilidade e reação uterina pós-inseminação em ovelhasFischer Neto, Arthur January 2009 (has links)
Este estudo teve por objetivo avaliar os efeitos de dois diluentes comerciais, Dilutris® (SEMENCON – Produtos Agropecuários Ltda., Porto Alegre, RS, Brasil) e TQC Holding Plus® (Nutricell – Nutrientes Celulares Ltda., Campinas, SP, Brasil), na qualidade do sêmen, nas taxas de concepção utilizando inseminação artificial cervical (IAC) e por laparoscopia (IAL) e na reação inflamatória uterina após a inseminação laparoscópica. Para os testes in vitro do sêmen foram coletados seis ejaculados de dois carneiros. Cada ejaculado foi dividido em cinco frações de 0,20 mL, e acrescentado a cada fração o volume de diluidor equivalente a concentração da dose inseminante: para IAC (100x106 espermatozóides) e para IAL (40x106 espermatozóides), formando quatro tratamentos T1, T2, T3 e T4, respectivamente: Dilutris®/cervical; Dilutris®/laparoscopia; Holding®/cervical; Holding®/laparoscopia. Foram avaliadas a motilidade/ vigor, testes de termo-resistência e hiposmótico de cada fração. A motilidade e o vigor não diferiram entre os tratamentos e foram semelhantes aos verificados no sêmen fresco. No teste hiposmótico, os valores verificados no T4 e T1 foram semelhantes e não diferiram dos observados no sêmen fresco. Os valores observados nos tratamentos T2 e T3 não diferiram entre si, mas foram significativamente inferiores (P<0,05) aos verificados no T4. Os resultados do teste de TTR verificados em todos os tratamentos utilizados, foram superiores ao valor mínimo de 30% preconizado pelo CBRA. O T1 apresentou valor significativamente inferior (P<0,05) ao dos demais tratamentos. Para a inseminação artificial, 208 fêmeas tiveram o estro sincronizado com esponjas vaginais contendo 60 mg de MAP por 13 dias e aplicação de 400 UI de eCG no momento da retirada. Foram inseminadas pela via cervical (IAC) ou por laparoscopia (IAL), 54 horas e 60 horas, respectivamente, após a retirada do dispositivo intra-vaginal, com sêmen diluído com Dilutris®, Holding® ou solução fisiológica (Grupo controle). Independentemente do diluente utilizado, os índices obtidos na IAL foram superiores (P<0,05) aos obtidos pela IAC. Na IAC a taxa de gestação obtida no grupo inseminado com o diluente TQC Holding Plus® (45,6%), foi semelhante à verificada no grupo controle (48,9%). Já no grupo que foi inseminado com Dilutris®, a taxa de gestação (29%) foi inferior à obtida no grupo controle (P<0,05). Com relação aos aspectos histológicos, verificou-se um infiltrado inflamatório de neutrófilos de grau discreto a acentuado nos úteros inseminados por laparoscopia com Dilutris®, de ausente a moderado nos úteros inseminados com TQC Holding Plus®, e no grupo controle não houve presença de infiltrado inflamatório de neutrófilos. Podese concluir que na avaliação in vitro, o meio de manutenção de embriões TQC Holding Plus® não causou efeitos negativos na qualidade do sêmen, enquanto que o meio diluidor Dilutris® foi menos efetivo na manutenção da qualidade do sêmen. O local de deposição do sêmen teve influência significativa no índice de fertilidade (P<0,05). Por laparoscopia as taxas de gestação foram semelhantes independentemente do diluidor utilizado. Um maior número de avaliações uterinas são necessárias para um melhor conhecimento da reação inflamatória intra-uterina em ovinos inseminados por laparoscopia. / This study aims to assess the effects of two commercial diluents, Dilutris® (SEMENCON – Produtos Agropecuários Ltda., Porto Alegre, RS, Brazil) and TQC Holding Plus® (Nutricell – Nutrientes Celulares Ltda., Campinas, SP, Brazil), on semen quality, conception rates using Cervical Artificial Insemination (CAI) and Laparoscopic Artificial Insemination (LAI), and uterine inflammatory reactions after the laparoscopic insemination. For the in vitro tests with the semen, six ejaculates of two rams were collected. Each ejaculate was divided into five fractions of 0.20 mL, and we added to each fraction the volume of extender equivalent to the concentration of the inseminant dose: for CAI (100x106 spermatozoa) and for LAI (40x106 spermatozoa), forming four treatments T1, T2, T3, and T4, respectively: Dilutris®/cervical; Dilutris®/laparoscopy; Holding®/cervical; Holding®/laparoscopy. The motility/vigor, thermo-resistance and hypoosmotic tests of each fraction was evaluated. The motility and vigor were not different between the treatments and were similar to those verified in fresh semen. In the hypoosmotic test, the values verified in T4 and T1 were similar and were not different from those observed in fresh semen. The values observed in T2 and T3 treatments have not differed between them, but were significantly lower (P<0.05) to those verified in T4. Results of the TTR test verified in all used treatments were superior to the minimum value of 30% preconized by CBRA. T1 presented a significantly lower value (P<0.05) compared to the other treatments. For artificial insemination, 208 female had their estrus synchronized with vaginal sponges containing 60 mg of MAP for 13 days and the application of 400 UI of eCG at the moment of removal. They were inseminated by cervical via (CAI) or by laparoscopy (LAI), 54 and 60 hours, respectively, after the removal of the intravaginal device, with semen diluted with Dilutris®, Holding® or physiological solution (control group). Independently of the extender used, the obtained rates in the LAI were superior (P<0.05) to those obtained with the CAI. In CAI the pregnancy rate obtained in the inseminated group with the TQC Holding Plus® diluent (45.6%) was similar to the one verified in the control group (48.9%). In the group inseminated with Dilutris®, the pregnancy rate (29%) was inferior to the obtained in the control group (P<0.05). Related to the histological aspects, we verified a discreet to accentuated degree of neutrophils inflammatory infiltrate in the uterus inseminated by laparoscopy with Dilutris®, from absent to moderate in uterus inseminated with TQC Holding Plus®, and in the control group there was not inflammatory infiltrate of neutrophils. We can conclude that in the in vitro evaluation, the embryos maintenance means TQC Holding Plus® has not caused negative effects in the quality of the semen, while the Dilutris® extender was less effective to maintain the quality of the semen. The semen deposition site has a significant impact in the fertility rate (P<0.05). By laparoscopy the pregnancy rates were similar independently of the extender used. A larger number of uterine analyses are required for a better knowledge of the intrauterine inflammatory reaction in sheep inseminated by laparoscopy.
|
8 |
Efeito de dois diluidores comerciais na qualidade do sêmen, fertilidade e reação uterina pós-inseminação em ovelhasFischer Neto, Arthur January 2009 (has links)
Este estudo teve por objetivo avaliar os efeitos de dois diluentes comerciais, Dilutris® (SEMENCON – Produtos Agropecuários Ltda., Porto Alegre, RS, Brasil) e TQC Holding Plus® (Nutricell – Nutrientes Celulares Ltda., Campinas, SP, Brasil), na qualidade do sêmen, nas taxas de concepção utilizando inseminação artificial cervical (IAC) e por laparoscopia (IAL) e na reação inflamatória uterina após a inseminação laparoscópica. Para os testes in vitro do sêmen foram coletados seis ejaculados de dois carneiros. Cada ejaculado foi dividido em cinco frações de 0,20 mL, e acrescentado a cada fração o volume de diluidor equivalente a concentração da dose inseminante: para IAC (100x106 espermatozóides) e para IAL (40x106 espermatozóides), formando quatro tratamentos T1, T2, T3 e T4, respectivamente: Dilutris®/cervical; Dilutris®/laparoscopia; Holding®/cervical; Holding®/laparoscopia. Foram avaliadas a motilidade/ vigor, testes de termo-resistência e hiposmótico de cada fração. A motilidade e o vigor não diferiram entre os tratamentos e foram semelhantes aos verificados no sêmen fresco. No teste hiposmótico, os valores verificados no T4 e T1 foram semelhantes e não diferiram dos observados no sêmen fresco. Os valores observados nos tratamentos T2 e T3 não diferiram entre si, mas foram significativamente inferiores (P<0,05) aos verificados no T4. Os resultados do teste de TTR verificados em todos os tratamentos utilizados, foram superiores ao valor mínimo de 30% preconizado pelo CBRA. O T1 apresentou valor significativamente inferior (P<0,05) ao dos demais tratamentos. Para a inseminação artificial, 208 fêmeas tiveram o estro sincronizado com esponjas vaginais contendo 60 mg de MAP por 13 dias e aplicação de 400 UI de eCG no momento da retirada. Foram inseminadas pela via cervical (IAC) ou por laparoscopia (IAL), 54 horas e 60 horas, respectivamente, após a retirada do dispositivo intra-vaginal, com sêmen diluído com Dilutris®, Holding® ou solução fisiológica (Grupo controle). Independentemente do diluente utilizado, os índices obtidos na IAL foram superiores (P<0,05) aos obtidos pela IAC. Na IAC a taxa de gestação obtida no grupo inseminado com o diluente TQC Holding Plus® (45,6%), foi semelhante à verificada no grupo controle (48,9%). Já no grupo que foi inseminado com Dilutris®, a taxa de gestação (29%) foi inferior à obtida no grupo controle (P<0,05). Com relação aos aspectos histológicos, verificou-se um infiltrado inflamatório de neutrófilos de grau discreto a acentuado nos úteros inseminados por laparoscopia com Dilutris®, de ausente a moderado nos úteros inseminados com TQC Holding Plus®, e no grupo controle não houve presença de infiltrado inflamatório de neutrófilos. Podese concluir que na avaliação in vitro, o meio de manutenção de embriões TQC Holding Plus® não causou efeitos negativos na qualidade do sêmen, enquanto que o meio diluidor Dilutris® foi menos efetivo na manutenção da qualidade do sêmen. O local de deposição do sêmen teve influência significativa no índice de fertilidade (P<0,05). Por laparoscopia as taxas de gestação foram semelhantes independentemente do diluidor utilizado. Um maior número de avaliações uterinas são necessárias para um melhor conhecimento da reação inflamatória intra-uterina em ovinos inseminados por laparoscopia. / This study aims to assess the effects of two commercial diluents, Dilutris® (SEMENCON – Produtos Agropecuários Ltda., Porto Alegre, RS, Brazil) and TQC Holding Plus® (Nutricell – Nutrientes Celulares Ltda., Campinas, SP, Brazil), on semen quality, conception rates using Cervical Artificial Insemination (CAI) and Laparoscopic Artificial Insemination (LAI), and uterine inflammatory reactions after the laparoscopic insemination. For the in vitro tests with the semen, six ejaculates of two rams were collected. Each ejaculate was divided into five fractions of 0.20 mL, and we added to each fraction the volume of extender equivalent to the concentration of the inseminant dose: for CAI (100x106 spermatozoa) and for LAI (40x106 spermatozoa), forming four treatments T1, T2, T3, and T4, respectively: Dilutris®/cervical; Dilutris®/laparoscopy; Holding®/cervical; Holding®/laparoscopy. The motility/vigor, thermo-resistance and hypoosmotic tests of each fraction was evaluated. The motility and vigor were not different between the treatments and were similar to those verified in fresh semen. In the hypoosmotic test, the values verified in T4 and T1 were similar and were not different from those observed in fresh semen. The values observed in T2 and T3 treatments have not differed between them, but were significantly lower (P<0.05) to those verified in T4. Results of the TTR test verified in all used treatments were superior to the minimum value of 30% preconized by CBRA. T1 presented a significantly lower value (P<0.05) compared to the other treatments. For artificial insemination, 208 female had their estrus synchronized with vaginal sponges containing 60 mg of MAP for 13 days and the application of 400 UI of eCG at the moment of removal. They were inseminated by cervical via (CAI) or by laparoscopy (LAI), 54 and 60 hours, respectively, after the removal of the intravaginal device, with semen diluted with Dilutris®, Holding® or physiological solution (control group). Independently of the extender used, the obtained rates in the LAI were superior (P<0.05) to those obtained with the CAI. In CAI the pregnancy rate obtained in the inseminated group with the TQC Holding Plus® diluent (45.6%) was similar to the one verified in the control group (48.9%). In the group inseminated with Dilutris®, the pregnancy rate (29%) was inferior to the obtained in the control group (P<0.05). Related to the histological aspects, we verified a discreet to accentuated degree of neutrophils inflammatory infiltrate in the uterus inseminated by laparoscopy with Dilutris®, from absent to moderate in uterus inseminated with TQC Holding Plus®, and in the control group there was not inflammatory infiltrate of neutrophils. We can conclude that in the in vitro evaluation, the embryos maintenance means TQC Holding Plus® has not caused negative effects in the quality of the semen, while the Dilutris® extender was less effective to maintain the quality of the semen. The semen deposition site has a significant impact in the fertility rate (P<0.05). By laparoscopy the pregnancy rates were similar independently of the extender used. A larger number of uterine analyses are required for a better knowledge of the intrauterine inflammatory reaction in sheep inseminated by laparoscopy.
|
9 |
Estudo histológico da ação do corticosteróide injetável no processo agudo de cicatrização das pregas vocais de coelhos / Histologic study of corticosteroid injection in the acute vocal fold wound healing in a rabbit modelAndréa Maria Campagnolo 29 October 2009 (has links)
Corticosteróides injetáveis têm sido usados em fonocirurgia com o intuito de se prevenir fibrose da prega vocal pelos seus efeitos na cicatrização e assegurar uma melhor qualidade vocal. O objetivo deste estudo é avaliar histologicamente os efeitos da infiltração de dexametasona no processo agudo de cicatrização, 3 e 7 dias após uma lesão induzida cirurgicamente na prega vocal de coelhos, através da análise quantitativa da reação inflamatória e da deposição de colágeno. Uma incisão cirúrgica foi realizada nas pregas vocais de 12 coelhos, seguido da injeção de 0,1ml de dexametasona na prega vocal esquerda. A prega vocal direita não recebeu nenhuma injeção e serviu como grupo controle. As laringes foram coletadas 3 e 7 dias após a cirurgia. As pregas vocais foram histologicamente analisadas com hematoxilina-eosina para quantificar a resposta inflamatória e picrossírius-red para quantificar a deposição de colágeno. Quantitativamente, não houve diferença significativa na resposta inflamatória das pregas vocais com corticosteróide em relação ao controle. A deposição de colágeno no grupo com corticóide foi estatisticamente menor em 3 dias e permaneceu menor em 7 dias após a lesão cirúrgica (p=0,002). Esses resultados sugerem que os corticosteróides diminuem a deposição do colágeno no processo agudo da cicatrização / Injectable corticosteroids have been used in phonosurgery to prevent scarring of the vocal fold due to their effects on wound healing, and to assure better voice quality. The aim of this study is to evaluate histologically the effects of dexamethasone infiltration on acute vocal fold wound healing in rabbits 3 and 7 days after surgically-induced injury, by quantification of the inflammatory reaction and collagen deposition. A standardized surgical incision was made in the vocal folds of 12 rabbits, and 0.1 ml dexamethasone (4 mg/ml) was injected into the left vocal fold. The right vocal fold was not injected and served as the control. The larynges were collected 3 and 7 days after surgery. For histological analysis, the vocal folds were stained with hematoxylin-eosin for quantification of the inflammatory response and with picrosirius red for quantification of collagen deposition. There was no quantitative difference in the inflammatory response between vocal folds injected with the corticosteroid and the control folds. However, collagen deposition was significantly lower in the corticosteroid-treated group at 3 and 7 days after the injury (p = 0.002). The present results suggest that dexamethasone reduces collagen deposition during acute vocal fold wound healing
|
10 |
NO Effect on Inflammatory Reaction in Extracorporeal Circulation : Ex vivo StudiesLahtinen, Mika January 2005 (has links)
<p>Nitric oxide (NO) is expressed in inflammatory tissues. However, NO effects are controversial in inflammation; NO is described as acting in a dose dependent manner and possess both pro-inflammatory and anti-inflammatory properties. </p><p>The present thesis explored the role of NO in relation to white blood cell (WBC) and protein system activation by foreign surfaces in simulated extracorporeal circulation (SECC) using human whole blood from volunteer donors. Three doses of NO, 40 ppm, 80 ppm and 500 ppm, were administered and an array of markers of WBC and protein activation were studied. Neutrophil degranulation was detected with myeloperoxidase (MPO), human neutrophil lipocalin (HNL) and lactoferrin (LF); eosinophil degranulation with eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO); and basophil degranulation with histamine. Furthermore, whole blood and WBC capacity to produce reactive oxygen species (ROS) were studied and cytokine release was measured with IL-1 and IL-10. Complement activation was measured with C3a and C5b-9 complex and contact system activation with FXIIa-C1INH, FXIIa-AT, FXIa-C1INH and FXIa-AT.</p><p>NO increased neutrophil degranulation at all dose levels and 80 ppm NO increased basophil degranulation; whereas, NO exerted no effect on eosinophil degranulation, WBC subset counts, cytokine release or capacity to produce ROS. In addition, while increasing both specific and azurophil degranulation with 40 ppm, 80 ppm and 500 ppm, NO reversed the classical degranulation hierarchy with 500 ppm and azurophil degranulation became predominant. Furthermore, NO effect was greater with 500 ppm than with 80 ppm, indicating a dose response effect. The lack of iNOS mRNA expression in WBC and lack of L-NAME effect on degranulation and nitrite/nitrate production, together with absent increase in nitrite/nitrate in controls, excluded autocrine or paracrine regulation of degranulation. FXIIa-AT and FXIa-AT complexes increased and became predominant during early recirculation, whereas FXIIa-C1INH and FXIa-C1INH complexes were predominant at baseline but remained unaltered, suggesting contact system inhibition predominantly via AT. C3a and C5b-C9 increased. NO had no effect on either contact or complement system activation; however, 500 ppm NO shortened active clotting time.</p><p>In conclusion, the present data suggest that NO has a direct effect on neutrophil and basophil degranulation. Recognition of NO as an enhancer of degranulation may give access to new therapeutic tools for local and systemic inflammatory therapies; whereas, the identification of increased AT mediated inhibition of FXIIa and unchanged C1INH complexes presents new possibilities for therapeutic intervention in conditions such as hereditary angioedema and heart surgery.</p>
|
Page generated in 0.071 seconds